NEW YORK (GenomeWeb) – Microbiologics today announced it has licensed Biomatrica's technology for use in its molecular controls for rapid diagnostic instruments and assays.

The deal covers Biomatrica's DNAstable and RNAstable reagents for stabilizing DNA and RNA standards, and combines the firms' biomaterial development expertise and preservation know-how "to create highly stable biological controls that may be globally delivered without cold-chain requirements," the firms said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.